A Study to Evaluate the Immune Response Features Following Vaccination With a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)
Clinical trial NCT07618325 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07618325
- Sponsor
- MAXVAX Biotechnology Limited Liability Company
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-02
- Primary completion
- 2028-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.